Healthcare Ai Acquisition's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Healthcare Ai Acquisition (HAIUF) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Healthcare Ai Acquisition vs Its Competitors
- Scale: Healthcare Ai Acquisition ranks #152 of 242 companies by market capitalization in the Blank Checks industry, holding 0.1% of industry market cap.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
API endpoints for this dataset
Healthcare Ai Acquisition's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Healthcare Ai Acquisition Corp | - | - | - | Yes |
| Competitors combined (1) | - | - | - | |
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
HAIUF Stock Performance relative to its Competitors
HAIUF Stock Performance relative to Similar-Size Competitors
Healthcare Ai Acquisition's Comment on Competition and Industry Peers
Publicly Traded Peers of Healthcare Ai Acquisition Corp
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Healthcare Ai Acquisition Corp |
16.97 | - |
 Strategic Acquisitions Inc |
17.74 | 0.08 |
| SUBTOTAL | 34.71 | 0.08 |
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Healthcare Ai Acquisition Corp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Healthcare Ai Acquisition's Competitors Named by the Company
Competitive relationships identified from Healthcare Ai Acquisition reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Strategic Acquisitions Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Healthcare Ai Acquisition's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Healthcare Ai Acquisition's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | 17 | - | - |
| Strategic Acquisitions Inc | 18 | 42,456 | -37,956 |
| PEERS TOTAL | 18 | 42,456 | -37,956 |
Healthcare Ai Acquisition's Position in Industry Market Structure
Market-capitalization share and concentration across all 175 companies in Healthcare Ai Acquisition's industry classification, broader than the peer set above. Market cap in millions of $.Healthcare Ai Acquisition ranks #152 of 175 companies by market capitalization in its industry, holding 0.06 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 118, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Dutch Oven Gold Group Inc | 1,644 | 5.61 % |
| 2 | Jaws Mustang Acquisition Corporation | 940 | 3.21 % |
| 3 | Constellation Acquisition Corp I | 677 | 2.31 % |
| 4 | Drugs Made In America Acquisition Ii Corp | 513 | 1.75 % |
| 5 | Cantor Equity Partners Iv Inc | 1,234 | 5.2% |
| 6 | Mntn Inc | 1,234 | 5.2% |
| 7 | Aldel Financial Ii inc | 1,234 | 5.2% |
| 8 | Gores Holdings X Inc | 1,234 | 5.2% |
| 9 | American Exceptionalism Acquisition Corp A | 1,234 | 5.2% |
| 10 | Crane Harbor Acquisition Corp Ii | 1,234 | 5.2% |
| 152 | Healthcare Ai Acquisition Corp | 17 | 0.06 % |
Market cap and industry share for the rest of Healthcare Ai Acquisition's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-10.
Healthcare Ai Acquisition's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 147 | Starry Sea Acquisition Corp | 20 | - |
| 148 | Quetta Acquisition Corporation | 20 | - |
| 149 | Rf Acquisition Corp Ii | 20 | 214.29 % |
| 150 | Dt Cloud Star Acquisition Corporation | 19 | - |
| 151 | Cslm Digital Asset Acquisition Corp Iii Ltd | 1,234 | 12.3% |
| 152 | Healthcare Ai Acquisition Corp | 17 | - |
| 153 | Ib Acquisition Corp | 1,234 | 12.3% |
| 154 | Jatt Ii Acquisition Corp | 1,234 | 12.3% |
| 155 | Sentinel Energy Services Inc | 1,234 | 12.3% |
| 156 | Bhav Acquisition Corp | 1,234 | 12.3% |
| 157 | Innventure Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Healthcare Ai Acquisition's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-11. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Healthcare Ai Acquisition's Valuation vs Competitive Position
Valuation multiples vs the Blank Checks industry average (65 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Blank Checks industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 46.1x | - |
| EV / EBITDA | - | 22.3x | - |
| P/B | -26.7x | 6.8x | -33.5x |
| Return on Equity | - | industry aggregate | - |
| Return on Invested Capital | - | -2.57 % (avg) | - |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Healthcare Ai Acquisition's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue Growth | - | - | - | - |
| Operating Margin | - | - | - | - |
| Return on Invested Capital | - | -0.57 % | -1.94 % | - |
| P/E | - | - | 39.0x | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Healthcare Ai Acquisition's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
Healthcare Ai Acquisition falls in the Question Mark quadrant: relative market share of 0.01x vs its largest competitor, in an industry growing revenue 26.9% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Healthcare Ai Acquisition's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 118 (see Industry Market Structure & Concentration above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Healthcare Ai Acquisition's dedicated Suppliers and Customers pages, not here.
Healthcare Ai Acquisition's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Healthcare Ai Acquisition falls in the Medium attractiveness / Low strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Healthcare Ai Acquisition's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Low relative market share vs the industry leader (0.01x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
- Industry revenue growing at a healthy 26.9% median pace.
- A meaningful share of competitors (100.00 %) show financial-distress signals, a possible opening to gain share.
Threats
No rule matched.
Methodology: see Methodology: SWOT Analysis.
Healthcare Ai Acquisition's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | 0.00 | 1.97 | - |
| Strategic Acquisitions Inc | 5.55 | 7.82 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Healthcare Ai Acquisition's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | Q2 2025 | - | - |
| Strategic Acquisitions Inc | Q2 2026 | - | - |
| PEERS TOTAL | - | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Healthcare Ai Acquisition's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | Q2 2025 | - | - |
| Strategic Acquisitions Inc | Q2 2026 | - | - |
Healthcare Ai Acquisition's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | - | - | - |
| Strategic Acquisitions Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Healthcare Ai Acquisition's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Healthcare Ai Acquisition Corp | - | - |
| Strategic Acquisitions Inc | - | 208.97 |
| PEERS AVERAGE | - | 408.83 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.